Lundbeck
HLUN-B.CO
#2771
Rank
โ‚น538.60 B
Marketcap
โ‚น542.86
Share price
0.92%
Change (1 day)
11.35%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): โ‚น52.79

According to Lundbeck's latest financial reports the company's current EPS (TTM) is โ‚น57.37. an increase over its 2024 EPS that were of โ‚น41.42.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025โ‚น47.4314.5%
2024โ‚น41.4229.29%
2023โ‚น32.0423.09%
2022โ‚น26.0337.26%
2021โ‚น18.96-84.61%
2020โ‚น123.23-24.61%
2019โ‚น163.44-42.06%
2018โ‚น282.0940.7%
2017โ‚น200.50146.26%
2016โ‚น81.42-120.48%
2015-โ‚น397.463231.32%
2014-โ‚น11.93-115.78%
2013โ‚น75.60-23.36%
2012โ‚น98.64-48.01%
2011โ‚น189.74-9.68%
2010โ‚น210.0913.72%
2009โ‚น184.7424.32%
2008โ‚น148.60-6.05%
2007โ‚น158.1781.77%
2006โ‚น87.01-16.76%
2005โ‚น104.54-17.58%
2004โ‚น126.84